Literature DB >> 14694957

Iloprost in persistent pulmonary hypertension of the newborn.

Michael Ehlen1, Beatrix Wiebe.   

Abstract

Aerosolized iloprost is now used as a therapeutic option in the treatment of pulmonary hypertension. We report on the administration of this derivative of prostacycline in treating severe pulmonary hypertension of the newborn. The combination of iloprost instilled endotracheally and inhaled was chosen as a last attempt at treatment in a critically ill patient who did not respond to advanced conventional treatments, including high frequency oscillation and inhalation of nitric oxide. The use of iloprost converted permanently the right-to-left shunting, leading to a substantial improvement in oxygenation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14694957     DOI: 10.1017/s1047951103000726

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  10 in total

1.  Iloprost drug delivery during infant conventional and high-frequency oscillatory ventilation.

Authors:  Robert M DiBlasi; Dave N Crotwell; Shuijie Shen; Jiang Zheng; James B Fink; Delphine Yung
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

Review 2.  Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates.

Authors:  Binoy Shivanna; Sharada Gowda; Stephen E Welty; Keith J Barrington; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2019-10-01

Review 3.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

4.  Update on PPHN: mechanisms and treatment.

Authors:  Jayasree Nair; Satyan Lakshminrusimha
Journal:  Semin Perinatol       Date:  2014-03       Impact factor: 3.300

Review 5.  Can we improve outcome of congenital diaphragmatic hernia?

Authors:  L van den Hout; I Sluiter; S Gischler; A De Klein; R Rottier; H Ijsselstijn; I Reiss; D Tibboel
Journal:  Pediatr Surg Int       Date:  2009-09       Impact factor: 1.827

Review 6.  Pharmacologic strategies in neonatal pulmonary hypertension other than nitric oxide.

Authors:  Satyan Lakshminrusimha; Bobby Mathew; Corinne L Leach
Journal:  Semin Perinatol       Date:  2016-01-14       Impact factor: 3.300

7.  Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine.

Authors:  Joe Brierley; Joseph A Carcillo; Karen Choong; Tim Cornell; Allan Decaen; Andreas Deymann; Allan Doctor; Alan Davis; John Duff; Marc-Andre Dugas; Alan Duncan; Barry Evans; Jonathan Feldman; Kathryn Felmet; Gene Fisher; Lorry Frankel; Howard Jeffries; Bruce Greenwald; Juan Gutierrez; Mark Hall; Yong Y Han; James Hanson; Jan Hazelzet; Lynn Hernan; Jane Kiff; Niranjan Kissoon; Alexander Kon; Jose Irazuzta; Jose Irazusta; John Lin; Angie Lorts; Michelle Mariscalco; Renuka Mehta; Simon Nadel; Trung Nguyen; Carol Nicholson; Mark Peters; Regina Okhuysen-Cawley; Tom Poulton; Monica Relves; Agustin Rodriguez; Ranna Rozenfeld; Eduardo Schnitzler; Tom Shanley; Saraswati Kache; Sara Skache; Peter Skippen; Adalberto Torres; Bettina von Dessauer; Jacki Weingarten; Timothy Yeh; Arno Zaritsky; Bonnie Stojadinovic; Jerry Zimmerman; Aaron Zuckerberg
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

Review 8.  Considerations in the management of hypoxemic respiratory failure and persistent pulmonary hypertension in term and late preterm neonates.

Authors:  S Lakshminrusimha; G G Konduri; R H Steinhorn
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

Review 9.  Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.

Authors:  Yogen Singh; Satyan Lakshminrusimha
Journal:  Clin Perinatol       Date:  2021-08       Impact factor: 2.642

Review 10.  Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices.

Authors:  Nathan Cosa; Edward Costa
Journal:  Med Devices (Auckl)       Date:  2016-04-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.